Expanding How We Heal: Ketamine, MDMA and Psilocybin

Ketamine, MDMA and psilocybin are generating growing interest in psychiatry, particularly for people who continue to struggle despite traditional treatments. Dr. Eve Glazier sits down with Jessica Jeffrey, MD, psychiatrist at the UCLA Semel Institute, about how psychedelic-assisted therapies are being studied, how they help people move beyond entrenched patterns of thinking, and why therapy and integration remain essential parts of the process. They also walk through the current evidence, potential risks, and what safe, responsible care looks like as this field continues to evolve.
Podcast Credits for UCLA Health Medically Speaking with Dr. Eve Glazier:
• Host: Dr. Eve Glazier
• Executive Producers: Annie Krasnow, Michael Burke
• Producers: Niki Miller, Jessica Alabastro
• Creative Producer: Kanza Shaheen
• Social Media and Communications: Bonnie Kim
• Technical Directors: Adrian Cardoso, Andrew Stocks
• Editor: Tony Sweet
• Recorded at: Canella Media
Special thanks to our expert guests and the incredible staff across UCLA Health who make this podcast possible. A special thank you to Johnese Spisso, President of UCLA Health and CEO of the UCLA Hospital System, for her visionary leadership and support. We are also grateful to the patients and families whose stories inspire our work every day.
Produced by: UCLA Health Communications & Marketing
Disclaimer: This podcast is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.